NASDAQ •
Healthcare •
Medical Devices •
Quote as of 06/26/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9,967.19 mln
Float68.99 mln
Earnings Date08/06/2026
EPS
4.28
Stretched
P / E
36.97
Overvalued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.47
Borderline
1-Year Forecast
242
Exceptional upside
Relative Strength
83
/ 100
Strongly outperforming
Business Description
Insulet Corporation designs and sells wearable insulin delivery devices for people living with insulin-dependent diabetes, serving customers across the United States and in markets around the world. The company is best known for its Omnipod product line, which offers tubeless, hands-free alternatives to traditional insulin pumps, including systems that automatically adjust insulin delivery by communicating wirelessly with glucose monitors. Beyond diabetes care, Insulet also supplies delivery pods used in a medical kit that helps protect cancer patients from infection following chemotherapy. Founded in 2000 and based in Acton, Massachusetts, the company reaches customers through pharmacies and distribution partners.